These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 38715255)

  • 1. Interrogating Estrogen Signaling Pathways in Human ER-Positive Breast Cancer Cells Forming Bone Metastases in Mice.
    Cheng JN; Frye JB; Whitman SA; Ehsani S; Ali S; Funk JL
    Endocrinology; 2024 Apr; 165(6):. PubMed ID: 38715255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Role for TGFβ Signaling in Preclinical Osteolytic Estrogen Receptor-Positive Breast Cancer Bone Metastases Progression.
    Cheng JN; Frye JB; Whitman SA; Kunihiro AG; Pandey R; Funk JL
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteolytic effects of tumoral estrogen signaling in an estrogen receptor-positive breast cancer bone metastasis model.
    Cheng JN; Frye JB; Whitman SA; Kunihiro AG; Brickey JA; Funk JL
    J Cancer Metastasis Treat; 2021; 7():. PubMed ID: 34790880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estradiol enhances osteolytic lesions in mice inoculated with human estrogen receptor-negative MDA-231 breast cancer cells in vivo.
    Winding B; Misander H; Høegh-Andersen P; Brünner N; Foged NT
    Breast Cancer Res Treat; 2003 Mar; 78(2):205-16. PubMed ID: 12725420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer.
    Shimo T; Kubota S; Yoshioka N; Ibaragi S; Isowa S; Eguchi T; Sasaki A; Takigawa M
    J Bone Miner Res; 2006 Jul; 21(7):1045-59. PubMed ID: 16813525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of osteolytic bone metastases.
    Guise TA
    Cancer; 2000 Jun; 88(12 Suppl):2892-8. PubMed ID: 10898330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin, but not curcumin-glucuronide, inhibits Smad signaling in TGFβ-dependent bone metastatic breast cancer cells and is enriched in bone compared to other tissues.
    Kunihiro AG; Brickey JA; Frye JB; Luis PB; Schneider C; Funk JL
    J Nutr Biochem; 2019 Jan; 63():150-156. PubMed ID: 30393127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 17β-estradiol on estrogen receptor negative breast cancer cells in an osteolytic mouse model.
    Cohen DJ; Patel V; Verma A; Boyan BD; Schwartz Z
    Steroids; 2019 Feb; 142():28-33. PubMed ID: 29133279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling.
    Johnson RW; Nguyen MP; Padalecki SS; Grubbs BG; Merkel AR; Oyajobi BO; Matrisian LM; Mundy GR; Sterling JA
    Cancer Res; 2011 Feb; 71(3):822-31. PubMed ID: 21189326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin Inhibition of TGFβ signaling in bone metastatic breast cancer cells and the possible role of oxidative metabolites.
    Kunihiro AG; Brickey JA; Frye JB; Cheng JN; Luis PB; Schneider C; Funk JL
    J Nutr Biochem; 2022 Jan; 99():108842. PubMed ID: 34407450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reprogramming of non-genomic estrogen signaling by the stemness factor SOX2 enhances the tumor-initiating capacity of breast cancer cells.
    Vazquez-Martin A; Cufí S; López-Bonet E; Corominas-Faja B; Cuyàs E; Vellon L; Iglesias JM; Leis O; Martín AG; Menendez JA
    Cell Cycle; 2013 Nov; 12(22):3471-7. PubMed ID: 24107627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells.
    Ariazi EA; Brailoiu E; Yerrum S; Shupp HA; Slifker MJ; Cunliffe HE; Black MA; Donato AL; Arterburn JB; Oprea TI; Prossnitz ER; Dun NJ; Jordan VC
    Cancer Res; 2010 Feb; 70(3):1184-94. PubMed ID: 20086172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis.
    Guise TA; Yin JJ; Taylor SD; Kumagai Y; Dallas M; Boyce BF; Yoneda T; Mundy GR
    J Clin Invest; 1996 Oct; 98(7):1544-9. PubMed ID: 8833902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss.
    Kim KR; Kim HJ; Lee SK; Ma GT; Park KK; Chung WY
    PLoS One; 2015; 10(4):e0122764. PubMed ID: 25859665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis.
    Zou Y; Tsai WB; Cheng CJ; Hsu C; Chung YM; Li PC; Lin SH; Hu MC
    Breast Cancer Res; 2008; 10(1):R21. PubMed ID: 18312651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a membrane-associated estrogen receptor in breast cancer cells and its contribution to hormone therapy resistance using a novel selective ligand.
    Niwa T; Takanobu J; Suzuki K; Sato Y; Yamaguchi Y; Hayashi SI
    J Steroid Biochem Mol Biol; 2020 Jul; 201():105671. PubMed ID: 32289430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat shock factor 1 (HSF1) cooperates with estrogen receptor α (ERα) in the regulation of estrogen action in breast cancer cells.
    Vydra N; Janus P; Kus P; Stokowy T; Mrowiec K; Toma-Jonik A; Krzywon A; Cortez AJ; Wojtas B; Gielniewski B; Jaksik R; Kimmel M; Widlak W
    Elife; 2021 Nov; 10():. PubMed ID: 34783649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Betulinic acid, a bioactive pentacyclic triterpenoid, inhibits skeletal-related events induced by breast cancer bone metastases and treatment.
    Park SY; Kim HJ; Kim KR; Lee SK; Lee CK; Park KK; Chung WY
    Toxicol Appl Pharmacol; 2014 Mar; 275(2):152-62. PubMed ID: 24463094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells.
    Amanatullah DF; Tamaresis JS; Chu P; Bachmann MH; Hoang NM; Collyar D; Mayer AT; West RB; Maloney WJ; Contag CH; King BL
    Breast Cancer Res; 2017 Nov; 19(1):121. PubMed ID: 29141657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers.
    Chiu JH; Wen CS; Wang JY; Hsu CY; Tsai YF; Hung SC; Tseng LM; Shyr YM
    J Transl Med; 2017 May; 15(1):97. PubMed ID: 28472954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.